Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XH8X
|
|||
| Former ID |
DIB008890
|
|||
| Drug Name |
APC-8015F
|
|||
| Synonyms |
CD54-postive autologous cell immunotherapy (hormone refractory prostate cancer), Dendreon
Click to Show/Hide
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0] | Phase 2 | [1] | |
| Company |
Dendreon Corp
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00849290) Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442). U.S. National Institutes of Health. | |||
| REF 2 | National Cancer Institute Drug Dictionary (drug id 561410). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.